checkAd

     152  0 Kommentare Ocular Therapeutix to Present Clinical Data at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - Seite 2


    Session Title: Ocular Surface Disease
    Session Date/Times: Monday, April 25, 2022 at 8:33 AM-8:38 AM ET
    Location: WEWCC, Level 1, 143A
    Presenter: Steven M. Silverstein, MD, FACS, ABO
  • Title: Real-World Allergic Conjunctivitis Treatment Patterns of Eye Care Providers
    Session Title: Ocular Surface Disease
    Session Date/Times: Monday, April 25, 2022 at 8:51 AM-8:56 AM ET
    Location: WEWCC, Level 1, 143A
    Presenter: William C. Christie, MD, ABO
  • Title: Patient Journey for Allergic Conjunctivitis and Initial Management
    Session Title: Ocular Surface Disease
    Session Date/Times: Monday, April 25, 2022 at 8:56 AM-9:01 AM ET
    Location: WEWCC, Level 1, 143A
    Presenter: Nandini Venkateswaran, MD, ABO
  • OTX-DED (dexamethasone intracanalicular insert) (Dry Eye Disease):

    • Title: Safety and Efficacy of OTX-DED, an Intracanalicular Dexamethasone Insert, for the Treatment of Episodic Dry Eye Disease: A Phase 2 Study
      Session Title: Ocular Surface Disease III
      Session Date/Times: Saturday April 23, 2022 at 3:30 PM-3:35 PM ET
      Location: WEWCC, Level 1, 144B
      Presenter: Lisa M. Nijm, MD, JD, ABO

    Investigator-Initiated Trials Presented at ASCRS:

    • Title: Thermal Pulsation with or without Dexamethasone Intracanalicular Insert for Meibomian Gland Dysfunction: A Prospective, Masked Trial
      Session Title: ASCRS Electronic Posters (On-Demand)
      Presenter: Paul Cacchillo, MD
    • Title: A Prospective, Randomized, Fellow Eye-Controlled Study of Post-Op Pain and Inflammation Control with DEXTENZA Insert Following SMILE
      Session Title: ASCRS Electronic Posters (On-Demand)
      Presenter: William F. Wiley, MD
    • Title: Dexamethasone Intracanalicular Insert at the Time of Surgery VS 4 Days Before for Combined Phaco and Trabecular Microbypass Implantation
      Session Title: ASCRS Electronic Posters (On-Demand)
      Presenter: Damien Goldberg, MD
    • Title: Prospective Study of Dexamethasone Ophthalmic Insert following Concomitant MIGS and Cataract Surgery
      Session Title: ASCRS LIVE Posters
      Session Date/Times: Sunday, April 24, 2022 at 3.10 PM-3:15 PM ET
      Location: Poster Pavilion, West Salon
      Presenter: Nicholas E. Tan, BA
    • Title: Intracanalicular Dexamethasone for Post-Corneal Cross-Linking Inflammation and Pain
      Session Title: Keratoconus
      Session Date/Times: Saturday, April 23, 2022 at 8:00 AM-8:05 AM ET
      Location: WEWCC, Level 1, 143C
      Presenter: Alanna S. Nattis, DO
    • Title: Efficacy of a Dexamethasone Intracanalicular Insert (OTX-DED), Compared to Loteprednol Suspension for the Treatment of Episodic Dry Eye
    Seite 2 von 4


    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Ocular Therapeutix to Present Clinical Data at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - Seite 2 Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced multiple scientific presentations at the …

    Schreibe Deinen Kommentar

    Disclaimer